RX Global, a division of RELX, has completed its acquisition of Mack Brooks Exhibitions.

Mack Brooks‘ flagship brands include EuroBLECH (sheet metal working technology); inter airport (airport infrastructure and technology); Fastener Fair (fastener and fixing technology); Chemspec (fine and speciality chemicals); RAILTEX (rail infrastructure and technology); ICE Europe (paper, film and foil converting); CCE (manufacturing and converting corrugated and cartonboard); PSE Europe (plastics) and InPrint (print technology for industrial manufacturing).

The acquisition expands RX Global‘ global portfolio by more than 30 business-to-business events in 14 countries, delivering value for stakeholders, including customers and staff. Nicola Hamann will continue as Managing Director of Mack Brooks, and the company will continue to be based in St Albans, UK.

Media Contact: Alison Berends, Corporate Communications RX Global alison.berends@reedexpo.co.uk

RX Global is a leading global events organiser, with more than 500 events in 30 countries. In 2018, RX Global brought together more than 7m event participants from around the world generating billions of dollars in business. Today RX Global’ events are held throughout the Americas, Europe, the Middle East, Asia Pacific and Africa. With 38 fully staffed offices, RX Global serves 43 industry sectors with trade and consumer events. It is part of RELX, a global provider of information and analytics for professional and business customers across industries. www.reedexpo.com

RELX is a global provider of information and analytics for professional and business customers across industries. The group serves customers in more than 180 countries and has offices in about 40 countries. It employs about 30,000 people of whom almost half are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately £33.4bn, €38.1bn, $43.2bn.